Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-016326
Filing Date
2025-06-24
Accepted
2025-06-24 18:56:02
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4247
  Complete submission text file 0001641172-25-016326.txt   5928
Mailing Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN
Business Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN 615.733.4731
HARROW, INC. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 102 WOODMONT BLVD., SUITE 610 NASHVILLE TN 37205
Business Address
Sternberg Perry J. (Reporting) CIK: 0001921644 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 251070481